HIV/AIDS and Drug Use in China—Interactions, Impacts, and Issues

REFERENCES

• Amass, L., Kamien, J. B., & Mikulich, S. K. (2000). Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet. Drug and Alcohol Dependence, 58, 143–52.
   PubMed Web of Science ®Google Scholar
• Amass, L., Ling, W., Freese, T. E., Reiber, C., Annon, J. J., Cohen, A. J., (2004). Bringing buprenorphine-naloxone detoxification to community treatment providers: The NIDA Clinical Trials Network field experience. American Journal on Addictions, 13(Suppl 1), 42–66.
   PubMed Web of Science ®Google Scholar
• Arasteh, K., & Des Jarlais, D. (2008). Injecting drug use, HIV, and what to do about it. Lancet, 372(9651), 1709–1710.
   PubMed Web of Science ®Google Scholar
• Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17, 377–381.
   PubMed Web of Science ®Google Scholar
• Berg, K. M., Mouriz, J., Li, X., Duggan, E., Goldberg, U., & Arnsten, J. H. (2009). Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics. Contemporary Clinical Trials, 30(5), 481–489.
   PubMed Web of Science ®Google Scholar
• Carrieri, M. P., Rey, D., Loundou, A., Lepeu, G., Sobel, A., Obadia, Y., & the MANIF-2000 Study Group. (2003). Evaluation of buprenorphine maintenance treatment in a French cohort of HIV-infected injecting drug users. Drug & Alcohol Dependence, 72(1), 13–21.
   PubMed Web of Science ®Google Scholar
• Carrieri, M. P., Vlahov, D., Dellamonica, P., Gallais, H., Lepeu, G., Spire, B., (2000). Use of buprenorphine in HIV infected injection drug users: Negligible impact on virological response to HAART. Drug and Alcohol Dependence, 60, 51–54.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2009). HIV-Associated Behaviors Among Injecting-Drug Users - 23 Cities, United States, May 2005-February 2006. Morbidity and Mortality Weekly Report (MMWR), 58, 329–332.
   PubMedGoogle Scholar
• China Ministry of Health, Ministry of Public Security and the State Food and Drug Administration. (2003). Opium abusers community-based drug maintenance treatment protocol. Beijing: Author.
   Google Scholar
• China Ministry of Health, Ministry of Public Security, and the State Food and Drug Administration (2006). Opium abusers community-based drug maintenance treatment protocol (trial version). Beijing: Author.
   Google Scholar
• China Ministry of Public Security. (2009). China national drug control report. Beijing: Author.
   Google Scholar
• China State Council. (2006). China HIV/AIDS prevention and treatment regulations. Beijing: Author.
   Google Scholar
• Compton, P. A., Wesson, D. R., Charuvastra, V. C., & Ling, W. (1996). Buprenorphine as a pharmacotherapy for opioid addiction. What dose provides a therapeutic response? The American Journal on Addictions, 5, 220–222.
   Web of Science ®Google Scholar
• Copenhaver, M., Lee, I. C., Harman, J., Johnson, B. T., & Carey, M. (2006). Behavioral HIV risk reduction among injection drug users: Meta-analytic evidence of efficacy. Journal of Substance Abuse Treatment, 31, 163–171.
   PubMed Web of Science ®Google Scholar
• Copenhaver, M., Bruce, R., & Altice, F. (2007). Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: A review of the empirical evidence. American Journal of Drug and Alcohol Abuse, 33(5), 643–654.
   PubMed Web of Science ®Google Scholar
• Essex, M., McLane, M. F., Lee, T. H., Falk, L., Howe, C. W., Mullins, J. I., (1983). Antibodies to cell membrane antigens associated with human T-cell leukemia virus in patients with AIDS. Science. May 20;220(4599), 859–62.
   PubMed Web of Science ®Google Scholar
• Fiellin, D. A., Rosenheck, R. A., & Kosten, T. R. (2001). Office-based treatment for opioid dependence: Reaching new patient populations. American Journal of Psychiatry, 158, 1200–1204.
   PubMed Web of Science ®Google Scholar
• Fudala, P. J., Bridge, T. P., Herbert, S., Chiang, C. N., Leiderman, D. B., & the Buprenorphine/Naloxone Collaborative Study Group. (1998). A multisite efficacy evaluation of a buprenorphine/naloxone product for opioid dependence treatment. NIDA Research Monograph, 179. Rockville: DHHS/NIH/NIDA: 105.
   Google Scholar
• Fudala, P. J., Bridge, T. P., Herbert, S., Williford, W. O., Chiang, C. N., Jones, K., (2003). Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. New England Journal of Medicine, 349(10), 949–958.
   PubMed Web of Science ®Google Scholar
• Gill, B., & Okie, S. (2007). China and HIV — a window of opportunity. New England Journal of Medicine, 7 May 3;356(18), 1801–1805.
   PubMed Web of Science ®Google Scholar
• Gosline, A. (2005). HIV epidemic sweeps along the heroin highways. New Scientist, 17, 18–26.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (1981). Pneumocystis pneumonia—Los Angeles. MMWR., 30, 250–252.
   PubMedGoogle Scholar
• Hinkin, C. H., Barclay, T. R., Castellon, S. A., Levine, A. J., Durvasula, R. S., Marion, S. D., (2007). Drug use and medication adherence among HIV-1 infected individuals. AIDS Behavior Mar; 11(2), 185–194.
   PubMed Web of Science ®Google Scholar
• International Harm Reduction Development Program (2008). Harm Reduction Developments 2008: Countries with Injection-Driven HIV Epidemics 2008, March. New York: Open Society Institute. Accessed on April 2009. and Retrieved from http:// www.soros.org/initiatives/health/focus/ihrd/articles_publications/ publications/developments_20080304
   Google Scholar
• Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000). A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. New England Journal of Medicine, 343, 1290–1297.
   PubMed Web of Science ®Google Scholar
• Kinlock, T. W., Gordon, M. S., Schwartz, R. P., O'Grady, K., Fitzgerald, T. T., & Wilson, M. (2007). A randomized clinical trial of methadone maintenance for prisoners: Results at 1-month post-release. Drug and Alcohol Dependence. 91(2–3), 220–227. Epub July 12, 2007.
   PubMed Web of Science ®Google Scholar
• Langford, D., Adame, A., Grigorian, A., Grant, I., Allen, M. J., Ellis, R. J., et al., & the HIV Neurobehavioral Research Center Group (2003). Patterns of selective neuronal damage in methamphetamine-user AIDS patients. Journal of Acquired Immune Deficiency Syndromes, 34, 467–474.
   PubMed Web of Science ®Google Scholar
• Li, X., Zhou, Y., & Stanton, B. (2002). Illicit drug initiation among institutionalized drug users in China. Addiction, 97, 575–582.
   PubMed Web of Science ®Google Scholar
• Ling, W., & Wesson, D. R. (2003). Clinical efficacy of buprenorphine: Comparisons to methadone and placebo. Drug and Alcohol Dependence, 70(2 Suppl), S49–S57.
   Google Scholar
• Ling, W., Amass, L., Shoptaw, S., Annon, J., Hillhouse, M., Babcock, D., et al., & the Buprenorphine Study Protocol Group. (2005). A multi center randomized trial of burprenorphine-naloxone and clonidine for opioid detoxification: Findings from the National Institute on Drug Abuse Clinical Trials Network. Addiction, 100(8), 1090–1100.
   PubMed Web of Science ®Google Scholar
• Ling, W., Charuvastra, V. C., Collins, J. F., Batki, S., Brown, L. S., Jr., Kintaudi, P., (1998). Buprenorphine maintenance treatment of opioid dependence: A multicenter randomized clinical trial. Addiction, 93, 475–486.
   PubMed Web of Science ®Google Scholar
• Ling, W., Wesson, D. R., Charuvastra, C., & Klett, C. J. (1998). A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Archives of General Psychiatry, 53, 401–407.
   Web of Science ®Google Scholar
• Liu, Z. M., Lu, X.-X., Lian, Z., Mu, Y., Guo, P., & An, X. (2004). Evaluation on drug dependence of buprenorphine. Acta Pharmacologica Sinica, 2003 May; 24(5), 448–452.
   Web of Science ®Google Scholar
• Lu, L., Jia, M. H., Zhang, X. B., Luo, H. B., Ma, Y. L., Fu, L. R., (2004). Analysis for epidemic trend of acquired immunodeficiency syndrome in Yunnan Province of China. Chinese Journal of Preventive Medicine, 5(38), 309–312.
   Google Scholar
• Lucas, G. M., Mullen, B. A., Weidle, P. J., Hader, S., McCaul, M. E., & Moore, R. D. (2006). Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups. Clinical Infectious Diseases. 42(11), 1628–1635. Epub 2006 Apr 28.
   PubMed Web of Science ®Google Scholar
• Mathers, B., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S., et al., & the Reference Group to the United Nations on HIV and injecting drug use. (2008). Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review.” Lancet, 327, (1951), 1733–1745.
   Google Scholar
• McCance-Katz, E. F., Rainey, P. M., Friedland, G., & Jatlow, P. (2003). The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients. Clinical Infectious Diseases, 37(4), 476–482.
   PubMed Web of Science ®Google Scholar
• McCoy, C. B., McCoy, H. V., Lai, S., Yu, Z., Wang, X., & Meng J. (2001). Reawakening the dragon:changing patterns of opiate use in Asia, with particular emphasis on China's Yunnan province. Substance Use and Misuse, 36, 49–69.
   PubMed Web of Science ®Google Scholar
• McCutchan, J. A., Wu, J. W., Robertson, K., Koletar, S. L., Ellis, R. J., Cohn, S., (2007). HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS, 21(9), 1109–1117.
   PubMed Web of Science ®Google Scholar
• Morris, M., Levine, R., & Weaver, M. (2004). Sexual networks and HIV program design. Advances through HIV/ AIDS research series. Seattle, WA: University of Washington. Retrieved from http://www.synergyaids.com/documents/SexualNetworksHIV ProgramDesign.pdf, accessed March 2008.
   Google Scholar
• Morris, M. (1997). Sexual networks and HIV. AIDS, 11(Suppl A), S209–S216.
   PubMed Web of Science ®Google Scholar
• Morris, M., & Kretzschmar, M. (1997). . Concurrent partnerships and the spread of HIV. AIDS, 11(5), 641–648.
   PubMed Web of Science ®Google Scholar
• National Institutes of Health; Office of NIH History (2010). In Their Own Words: NIH Researchers Recall the Early History of AIDS. Accessed on May 2009. Retrieved from http://aidshistory.nih.gov/timeline/index.html
   Google Scholar
• Pang, L., Hao, Y., Mi, G., Wang, C., Luo, W., Rou, K., (2007). Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS, 21(Suppl 8), S103–S107.
   PubMed Web of Science ®Google Scholar
• Peck, J. A., Shoptaw, S., Rotheram-Fuller, E., Reback, C. J., & Bierman, B. (2005). HIV-associated medical, behavioral, and psychiatric characteristics of treatment-seeking methamphetamine-dependent men who have sex with men. Journal of Addictive Diseases, 24, 115–132.
   PubMed Web of Science ®Google Scholar
• Qian, H. Z., Schumacher, J. E., Chen, H. T., & Ruan, Y. H. (2006). Injection drug use and HIV/AIDS in China: Reviewof current situation, prevention and policy implications. Harm Reduction Journal, 3(1), 4.
   PubMedGoogle Scholar
• Rainey, P. M., Friedland, G. H., Snidow, J. W., McCance-Katz, E. F., Mitchell, S. M., Andrews, L., (2002). The pharmacokinetics of methadone following coadministration with a lamivudine/zidovudine combination tablet in opiate-dependent subjects. American Journal on Addictions, 11(1), 66–74.
   PubMed Web of Science ®Google Scholar
• Rich, J. D., McKenzie, M., Shield, D. C., Wolf, F. A., Key, R. G., Poshkus, M., (2005). Linkage with methadone treatment upon release from incarceration: A promising opportunity. Journal of Addictive Diseases, 24(3), 49–59.
   PubMed Web of Science ®Google Scholar
• Shoptaw, S., & Reback, C. J. (2006). Associations between methamphetamine use and HIV infection in men who have sex with men: A model for guiding public policy. Journal of Urban Health, 83(6), 1151–1157.
   PubMed Web of Science ®Google Scholar
• State Council AIDS Working Committee Office and UN Theme Group on AIDS in China. (2007). A joint assessment of HIV/AIDS prevention treatment and care in China. Beijing: Author.
   Google Scholar
• Sullivan, L. E., Metzger, D. S., Fudala, P. J., & Fiellin, D. A. (2005). Decreasing international HIV transmission: The role of expanding access to opioid agonist therapies for injection drug users. Addiction, 100, 150–158.
   PubMed Web of Science ®Google Scholar
• Sullivan, S., & Wu, Z. (2007). Rapid scale up of harm reduction in China. International Journal of Drug Policy, 18, 118–128.
   PubMed Web of Science ®Google Scholar
• Tang, Y.-L., & Jiang, Z.-M. (1998). The use of buprenorphine in the treatment of heroin addiction in China: A review. Hong Kong Journal of Psychiatry, 8(1), 21–23.
   Google Scholar
• United Nations. (2001). Position Paper: Preventing the Transmission of HIV Among Drug Abusers. Accessed on May 2009. Retrieved from http://www.cicad.oas.org/en/Resources/ UNHIVaids.pdf
   Google Scholar
• UNODC (2009). UNODC: treatnet capacity building. Retrieved from http://www.unodc.org/treatment and http://www. uclaisap.org/InternationalProjects/html/unodc/training- package-intro.html.
   Google Scholar
• Wang, L. (2007). Overview of the HIV/AIDS epidemic, scientific research and government responses in China. AIDS, 21(Suppl 8), S3–S7.
   PubMed Web of Science ®Google Scholar
• Ward, J., Mattick, R. P., & Hall, W. (1998). The effectiveness of methadone maintenance treatment 2: HIV and infectious hepatitis. In J. Ward, R. P. Mattick & W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 59–73). Amsterdam: Harwood Academic Publishers.
   Google Scholar
• WHO (World Health Organization; UNAIDS) (2006a). AIDS Epidemic Update, 2006. Accessed on May 2009. Retrieved from http: //www.unaids.org/en/KnowledgeCentre/HIVData/ EpiUpdate/EpiUpdArchive/2006/Default.asp
   Google Scholar
• WHO (World Health Organization; UNAIDS) (2006b). Epidemiological fact sheets on HIV/AIDS and sexually transmitted infections: China. Geneva, Switzerland;. Accessed on June 2009. Retrieved from http: //www.who.int/globalatlas/ predefinedReports/EFS2006/EFS_PDFs/EFS2006_CN.pdf]
   Google Scholar
• Wu, Z. (2008). Summary of the HIV/AIDS prevention in 2007 and workplan for 2008. Presented at the 2008 Annual Meeting of the Provincial AIDS Directors. Beijing, China; Accessed on January 23.
   Google Scholar
• Wu, Z., Rou, K., & Cui, H. (2004).The HIV/AIDS epidemic in China: History, current strategies and future challenges. AIDS Education and Prevention, 16(3 Suppl A), 7–17.
   PubMed Web of Science ®Google Scholar
• Wu, Z., Zhang, J., Detels, R., Li, V. C., Cheng, H., Duan, S., (1997). Characteristics of risk-taking behaviors, HIV and AIDS knowledge, and risk perception among young males in southwest China. AIDS Education and Prevention, 9(2), 147–160.
   PubMed Web of Science ®Google Scholar
• Zhang, F., Haberer, J. E., Wang, Y., Zhao, Y., Ma, Y., Zhao, D., (2007). The Chinese free antiretroviral treatment program: Challenges and responses. AIDS, 21(Suppl 8), S143–S148.
   PubMed Web of Science ®Google Scholar